Delivery Order SPE2DR25D1106-SPE2DR26FJC4B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,258.10 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 31, 2025, and was issued on October 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.74 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,760.90 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child delivery order, this award falls under the company's larger...
- The Defense Logistics Agency awarded a $29,398.41 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial infections. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 24, 2025, for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This firm fixed-price delivery order, valued at $5,719.88 with an ultimate completion date of October 27, 2025, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $4,481.35 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials on April 22, 2025, with a completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. This delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for 500 mg vials of Dalvance (dalbavancin), a broad-spectrum antibiotic, with a ceiling value of $3,658.32. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was awarded on August 4, 2025. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with a ceiling value of $2,743.74. The award, issued on September 4, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,552.47 firm fixed price delivery order to AmerisourceBergen Drug Corp for DALVANCE 500 mg vials, with an ultimate completion date of October 24, 2025. The award was made without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $2,688.81 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a specialty antibiotic used to treat bacterial skin infections. This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJC4BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,854.30 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued December 5, 2025, is due for completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements in open competition. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 12/4/25 |